Transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma of the parotid gland is independent of p53 mutations

Journal of Surgical Oncology

Volumn 101, Issue 2, 2010, Pages 127-130

  Gedlicka, Claudia ^a   Item, Chike B ^a   Wögerbauer, Markus ^a   Martinek, Helga ^a   Heiduschka, Gregor ^a   Erovic, Boban M ^a   Grasl, Matthaeus Ch ^a   Thurnher, Dietmar ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CARCINOMA EX PLEOMORPHIC ADENOMA; CLINICAL ARTICLE; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA EXTRACTION; DNA SEQUENCE; EXON; FEMALE; GENE LOSS; GENE MUTATION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; MUTATIONAL ANALYSIS; PAROTID GLAND CARCINOMA; PLEOMORPHIC ADENOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS;

ADENOMA, PLEOMORPHIC; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; PAROTID NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 76549097704     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21444     Document Type: Article

References (28)

1. Strutz J, Mann W, editors. Praxis der HNO-Heilkunde, Kopf- und Halschirurgie. Stuttgart: Thieme; 2001. pp 473-479.
2. Declercq J, Van Dyck F, Van Damme B, et al.: Upregulation of Igf and Wnt singnalling associated genes in pleomorphic adenomas of the salivary glands in PLAG1 transgenic mice. Int J Oncol 2008;32:1041-1047.
3. Nordkvist A, Roijer E, Bang G, et al.: Expression and mutation patterns of p53 in benign and malignant salivary gland tumors. Int J Oncol 2000;16:477-483.
4. Freitas L, Araujo V, Martins M, et al.: Biomarker analysis in carcinoma wx pleomorphic adenoma at an early phase of carcinomatous transformation. Int J Surg Pathol 2005;13:337-342.
5. Lamb P, Crawford L: Characterization of the human p53 gene. Mol Cell Biol 1986;6:1379-1385.
6. Goan Y, Chang H, Hsu H, et al.: Risk of p53 gene mutation in esophageal squamous cell carcinoma and habit of betel quid chewing in Taiwanese. Cancer Sci 2005;96:758-765.
7. Breton J, Sichel F, Abbas A, et al.: Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area. Mutatgenesis 2003;18:299-306.
8. Li X, Tsuji T,Wen S, et al.: Detection of numeric abnormalities of chromosome 17 and p53 deletions by fluorescence in situ hybridization in pleomorphic adenomas and carcinomas in pleomorphic adenoma. Correlation with p53 expression. Cancer 1997;79:2314-2319.
9. Kärjä VJ, Syrjänen KJ, Kurvinen AK, et al.: Expression and mutations of p53 in salivary gland tumours. J Oral Pathol Med 1997;26:217-223.
10. Matizonkas-Antonio L, de Mesquita R, de Souza S, et al.: TP53 mutations in salivary gland neoplasms. Braz Dent J 2005;16:162-166.
11. Altemani A, Martins MT, Freitas I, et al.: Carcinoma ex pleomorphic adenoma (CXPA): Immunoprofile of the cells involved in carcinomatous progression. Histopathology 2005; 46:635-641.
12. Guldberg P, Nedergaard T, Nielsen HJ, et al.: Single-step DGGE-based mutation scanning of the p53 gene: Application to genetic diagnosis of colorectal cancer. Hum Mutat 1997;9:348-355.
13. Bosch FX, Homann N, Conradt C, et al.: p53 mutation/p53-protein over expression. Differential significance for the progression of head-neck carcinomas. HNO 1999;47:833-848.
14. Koch WM, Brennan JA, Zahurak M, et al.: P53 mutation and locoregional treatment failure in head and neck squmaous cell carcinoma. J Natl Cancer Inst 1996;88:1580-1586.
15. Ferretti G, Curigliano G, Pastorino U, et al.: Detection by denaturant gradient gel electrophoresis of tumor-specific mutation in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer. Clin Cancer Res 2000;6: 2393-2400.
16. Timmers C, Sharma N, Opavsky R, et al.: E2f1-3 control E2F-target expression and cellular proliferation via a p53-dependent negative feedback loop. Mol Cell Biol 2007;27:65-78.
17. Agirre X, Novo FJ, Calasanz MJ, et al.: TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia. Mol Carcinog 2003;38:201-208.
18. Kropveld A, van Masfeld AD, Nabben N, et al.: Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients. Eur J Cancer B Oral Oncol 1996;32B:388-393.
19. Alves FA, Pires FR, De Almeida OP, et al.: PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours. Int J Oral Maxillofac Surg 2004;33:593-597.
20. Yamamoto Y, Kishimoto Y, Virmani AK, et al.: Mutations associated with carcinomas arising from pleomorphic adenomas of the salivary glands. Hum Pathol 1996;27:782-786.
21. Fowler M, Fowler J, Ducatman B, et al.: Malignant mixed tumors of the salivary gland: A study of loss of heterozygosity in tumor suppressor genes. Mod Pathol 2006;19:350-355.
22. Felix A, Rosa JC, Fonseca I, et al.: Laminin and collagen IV in pleomorphic adenoma: An immunohistochemical study. Hum Pathol 1999;30:964-969.
23. Ostwald C, Gogacz P, Hillmann T, et al.: P53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity. Int J Cancer 2000;88:82-86.
24. Alsner J, Sorensen SB, Overgaard J: TP53 mutations is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck. Radiother Oncol 2001; 59:179-185.
25. Sathyan KM, Sailasree R, Kayasurya R, et al.: Carcinoma of tongue and the buccal mucosa represent different biological subentities of the oral carcinoma. J Cancer Res Clin Oncol 2006; 132:601-609.
26. Vora HH, Trivedi TI, Shukla SN, et al.: P53 expression in leukoplakia and carcinomas of the tongue. Int J Biol Markers 2006;21:74-80.
27. Grignon DJ, Caplan R, Sarkar FH, et al.: p53 status and prognosis of locally advanced prostatic adenocarcinoma: A study based on RTOG 8610. J Natl Cancer Inst 1997;89:158-165.
28. Rines RD, van Orsouw NJ, Sigalas I, et al.: Comprehensive mutational scanning of the p53 coding region by two-dimensional gene scanning. Carcinogenesis 1998;19:979-984.